Skip to main content
Displaying 1 - 12 of 13
Display:
12
24
48
Viral Hepatitis
1
GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session) - EASL Congress 2024
View
Viral Hepatitis
1
GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session) - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
5
Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024
View
Viral Hepatitis
5
Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024
View
Viral Hepatitis
5
Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024
View
Viral Hepatitis
5
Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy